Nonetheless, the assessment of insulin action may be clinically relevant in GDM and even in pregnant women with overweight, obesity or with signs of dysglycemia (though in the absence of overt GDM), since the degree of insulin resistance can drive specific therapeutic intervention and care [18, 19]. The gene discussed is INS; the disease is gestational diabetes.